Cargando…

Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells

ARID1A, a component of the SWI/SNF chromatin remodeling complex, is a tumor suppressor with a high frequency of inactivating mutations in many cancers. Therefore, ARID1A deficiency has been exploited therapeutically for treating cancer. Here we show that ARID1A has a synthetic lethal interaction wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Changjie, Lyu, Junfang, Yang, Eun Ju, Liu, Yifan, Zhang, Baoyuan, Shim, Joong Sup
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086874/ https://www.ncbi.nlm.nih.gov/pubmed/30097580 http://dx.doi.org/10.1038/s41467-018-05694-4

Ejemplares similares

Histone Acetyltransferase (HAT) P300/CBP Inhibitors Induce Synthetic Lethality in PTEN-Deficient Colorectal Cancer Cells through Destabilizing AKT
por: Liu, Yifan, et al.
Publicado: (2020)

Class I histone deacetylase inhibition is synthetic lethal with BRCA1 deficiency in breast cancer cells
por: Zhang, Baoyuan, et al.
Publicado: (2020)

Synthetic lethality of RB1 and aurora A is driven by stathmin-mediated disruption of microtubule dynamics
por: Lyu, Junfang, et al.
Publicado: (2020)

ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A
por: Williamson, Chris T., et al.
Publicado: (2016)

ETMM-04. AURKA INHIBITION REPROGRAMS METABOLISM AND IS SYNTHETICALLY LETHAL WITH FATTY ACID OXIDATION INHIBITION IN GLIOBLASTOMA MODEL SYSTEMS
por: Nguyen, Trang, et al.
Publicado: (2021)

Targeting the TCA cycle through cuproptosis confers synthetic lethality on ARID1A-deficient hepatocellular carcinoma
por: Xing, Tao, et al.
Publicado: (2023)

Aurora kinase A, a synthetic lethal target for precision cancer medicine
por: Mou, Pui Kei, et al.
Publicado: (2021)

Mapping the Synthetic Dosage Lethality Network of CDK1/CDC28
por: Zimmermann, Christine, et al.
Publicado: (2017)

MDM2 inhibition is synthetic lethal with PTEN loss in colorectal cancer cells via the p53-dependent mechanism
por: Ren, Guowen, et al.
Publicado: (2023)

Cholesterol Trafficking: An Emerging Therapeutic Target for Angiogenesis and Cancer
por: Lyu, Junfang, et al.
Publicado: (2019)

Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response
por: Mandal, Jayaprakash, et al.
Publicado: (2022)

cdc-25.4, a Caenorhabditis elegans Ortholog of cdc25, Is Required for Male Mating Behavior
por: Oh, Sangmi, et al.
Publicado: (2016)

Astemizole Inhibits mTOR Signaling and Angiogenesis by Blocking Cholesterol Trafficking
por: Lyu, Junfang, et al.
Publicado: (2018)

Targeting EZH2 methyltransferase activity in ARID1A mutated cancer cells is synthetic lethal
por: Biter, Benjamin G., et al.
Publicado: (2015)

Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers
por: Kelso, Timothy W R, et al.
Publicado: (2017)

Silencing of AURKA augments the antitumor efficacy of the AURKA inhibitor MLN8237 on neuroblastoma cells
por: Yang, Yan, et al.
Publicado: (2020)

AURKA inhibition mimics BRCAness
por: Hirst, Jeff, et al.
Publicado: (2017)

PUF60/AURKA Axis Contributes to Tumor Progression and Malignant Phenotypes in Bladder Cancer
por: Long, Qian, et al.
Publicado: (2020)

Bexarotene – a novel modulator of AURKA and the primary cilium in VHL-deficient cells
por: Chowdhury, Pratim, et al.
Publicado: (2018)

PARG deficiency is neither synthetic lethal with BRCA1 nor PTEN deficiency
por: Noll, Aurélia, et al.
Publicado: (2016)

Leflunomide triggers synthetic lethality in PTEN-deficient prostate cancer
por: Ozturk, Sait, et al.
Publicado: (2020)

STIL/AURKA axis promotes cell proliferation by influencing primary cilia formation in bladder cancer
por: Li, Jingxian, et al.
Publicado: (2023)

Expression of cdc25A and cdc25B proteins in thyroid neoplasms
por: Ito, Y, et al.
Publicado: (2002)

Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency
por: Bajrami, Ilirjana, et al.
Publicado: (2021)

Integrated pan‐cancer of AURKA expression and drug sensitivity analysis reveals increased expression of AURKA is responsible for drug resistance
por: Miralaei, Noushin, et al.
Publicado: (2021)

Reciprocal deregulation of NKX3.1 and AURKA axis in castration-resistant prostate cancer and NEPC models
por: Sooreshjani, Moloud Aflaki, et al.
Publicado: (2021)

Cdc25b and Cdc25c Differ Markedly in Their Properties as Initiators of Mitosis
por: Karlsson, Christina, et al.
Publicado: (1999)

Modeling synthetic lethality
por: Le Meur, Nolwenn, et al.
Publicado: (2008)

Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis
por: Zhang, Meng-Yu, et al.
Publicado: (2018)

Development of 'synthetic lethal' strategies to target BRCA1-deficient breast cancer
por: Wicha, Max S
Publicado: (2009)

Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency
por: Han, Mingqi, et al.
Publicado: (2019)

VRK1 Is a Synthetic–Lethal Target in VRK2-Deficient Glioblastoma
por: Shields, Julie A., et al.
Publicado: (2022)

Bioinformatics and experimental validation of an AURKA/TPX2 axis as a potential target in esophageal squamous cell carcinoma
por: Du, Ruijuan, et al.
Publicado: (2023)

Human Cdc14A Phosphatase Modulates the G2/M Transition through Cdc25A and Cdc25B
por: Vázquez-Novelle, María D., et al.
Publicado: (2010)

Aurka deficiency in the intestinal epithelium promotes age-induced obesity via propionate-mediated AKT activation
por: Sun, Na, et al.
Publicado: (2021)

Therapeutically actionable signaling node to rescue AURKA driven loss of primary cilia in VHL-deficient cells
por: Chowdhury, Pratim, et al.
Publicado: (2021)

A human cancer-predisposing polymorphism in Cdc25A is embryonic lethal in the mouse and promotes ASK-1 mediated apoptosis
por: Bahassi, El Mustapha, et al.
Publicado: (2011)

Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus
por: Nishioka, K, et al.
Publicado: (2001)

Targeting USP9X–AMPK Axis in ARID1A-Deficient Hepatocellular Carcinoma
por: Zhang, Feng-Kun, et al.
Publicado: (2022)

Akt-p53-miR-365-cyclin D1/cdc25A axis contributes to gastric tumorigenesis induced by PTEN deficiency
por: Guo, Shui-Long, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rbrf264h7pni75hulbk8542ujt